Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Aurora Cannabis Inc.NASDAQ: ACB

Gross Profit · Q4 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q4 FY2026 gross profit of CA$18.17M fell 17.0% year over year, behind the -6.1% change in trailing-twelve-month gross profit. Sequentially, it fell 61.0% from the prior quarter. Over 3 fiscal years it compounded at +4.2% a year.

Context

  • Gross profit amounted to 5.2% of revenue in FY2026, down 49.4 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -17.0% toward the trailing-twelve-month pace of -6.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$18.17M-61.0% QoQ
Last fiscal yearMar 2026
CA$16.75M-91.1% YoY
LTMMar 2026
CA$176.08M-6.1% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.0%——
1 year-91.1%——
3-year CAGR+4.2%——
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2026
16.75M CAD
Year-over-year change
-91.1%
4-year CAGR
-5.8%

Gross Profit vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -6.1% is the 8th highest of 10, against a peer median of +54.0%.
  • Gross profit amounts to 56.6% of revenue for ACB, versus a peer median of 34.5%.
ACB Competitors
Gross Profit for ACB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026$360.13M USD+38.3%-10.2%99.6%
LFMDLifeMD, Inc.LTM Mar 2026$188.46M USD-8.4%+15.5%85.9%
ACBAurora Cannabis Inc.LTM Mar 2026CA$176.08M CAD-6.1%+4.2%56.6%
HITIHigh Tide Inc.LTM Apr 2026CA$117.63M CAD-17.2%+15.0%17.5%
OGIOrganigram Global Inc.LTM Mar 2026CA$97.71M CAD+54.0%—35.6%
CGCCanopy Growth CorporationLTM Mar 2026CA$77.66M CAD-2.3%—24.9%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$42.13M USD—+1.0%31.2%
TKNOAlpha Teknova, Inc.LTM Mar 2026$13.93M USD+73.5%-8.4%33.3%
BIOABioAge Labs, Inc.LTM Mar 2026$10.25M USD+606.6%—99.4%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$6.39M USD+74.8%-31.4%76.3%
EDITEditas Medicine, Inc.LTM Mar 2026$2.25M USD+105.3%+44.7%5.8%
Peer median (excluding ACB) —+54.0%+1.0%34.5%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.